PI-103 CAS: 371935-74-9
MF: C19H16N4O3
MW: 348.36
An ATP-competitive DNA-PK, PI 3-kinase, and FRAP inhibitor.

PI-103 (CAS 371935-74-9)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 124ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
PI-103 is rated 5.0 out of 5 by 1.
5
1
4
0
3
0
2
0
1
0
Alternativa namn: PI 3-K Inhibitor V
Ansökan PI-103 is an ATP-competitive DNA-PK, PI 3-kinase, and FRAP inhibitor
CAS Nr: 371935-74-9
Renhet: 99%
Molekylvikt: 348.36
Molekylär formel: C19H16N4O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).

PI-103 is a cell-permeable pyridinylfuranopyrimidine compound that acts as an ATP-competitive inhibitor of DNA-PK, PI 3-kinase (Class IA), and FRAP (mTOR) complex 1 and 2. Studies suggest that PI-103 can induce apoptosis and an arrest in the cell cycle by inhibition of the aforementioned proteins. When PI-103 is combined with rapamycin, a prototypic mTORC1 inhibitor, synergistic suppression of AKT and ribosomal S6 protein phosphorylation are observed. In addition, PI-103 has been seen to have nominal effects inhibiting basal Na+ transport, but is very effective in abolishing insulin-induced Na+ absorption in the nephron.


Konferenser

1. Demyanets, S., et al. 2010. Basic Res Cardiol. [Epub ahead of print]. PMID: 21174212
2. Mansley, M.K., et al. 2010. Br. J. Pharmacol. 161: 571-588. PMID: 20880397
3. Bagci-Onder, T., et al. 2010. Cancer Res. [Epub ahead of print]. PMID: 21084267
4. Werzowa, J., et al. 2010. J. Invest. Dermatol. [Epub ahead of print]. PMID: 21048785

Physical State :
Solid
Solubility :
Soluble in DMSO (10 mg/ml), DMF (10 mg/ml), 1:2 DMSO:PBS(pH 7.2) (0.25 mg/ml), water (<1 mg/ml) at 25° C, and ethanol (<1 mg/ml) at 25° C.
LAGRING :
Store at -20° C
Melting Point :
231.64° C (Predicted)
Boiling Point :
520.25° C at 760 mmHg (Predicted)
Density :
1.41 g/cm3 (Predicted)
Refractive Index :
n20D 1.71
IC50 :
DNA-PK: IC50 = 2 nM; p110α: IC50 = 8 nM; p110β: IC50 = 88 nM; p110δ: IC50 = 48 nM; p110γ: IC50 = 150 nM; PI3-KC2β: IC50 = 26 nM; mTORC1: IC50 = 20 nM; mTORC2: IC50 = 83 nM; ATR: IC50 = 850 nM; ATM: IC50 = 920 nM; PI 3-KC2α: IC50 = ~ 1 µM; hsVPS34: IC50 = 2.3 µM
Ki Data :
Cdk5/p25: Ki= 2 µM; p33cdk2/cyclin E: Ki= 2 µM
pK Values :
pKa: 9.06 (Predicted), pKb: 2.97 (Predicted)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
PubChem CID :
MDL Number :
MFCD11983145
SMILES :
C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

PI-103 (CAS 371935-74-9)  Produkt Citat

See how others have used PI-103 (CAS 371935-74-9). Click on the entry to view the PubMed entry .

Citations 1 to 3 of 3 total

PMID: # 30731136  Höllerhage, M. et al. 2019. Neuropharmacology. 149: 13-26.

PMID: # 26355082  Kwon, YC. et al. 2015. J. Virol. 89: 11549-56.

PMID: # 17804702  Fan, QW. et al. 2007. Cancer Res. 67(17): 7960-7965.

Citations 1 to 3 of 3 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 106ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 5ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.